These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21228606)

  • 1. Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease.
    Hori K; Konishi K; Watanabe K; Uchida H; Tsuboi T; Moriyasu M; Tominaga I; Hachisu M
    Neuropsychobiology; 2011; 63(3):147-53. PubMed ID: 21228606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
    Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
    Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum anticholinergic activity: relationship with clinical symptoms in Alzheimer's disease and proposal of new biological marker].
    Hori K; Konishi K; Hachisu M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):135-40. PubMed ID: 21800705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral profile of Alzheimer's disease in Chinese elderly--a validation study of the Chinese version of the Alzheimer's disease behavioral pathology rating scale.
    Lam LC; Tang WK; Leung V; Chiu HF
    Int J Geriatr Psychiatry; 2001 Apr; 16(4):368-73. PubMed ID: 11333423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic serum levels and cognitive performance.
    Thienhaus OJ; Allen A; Bennett JA; Chopra YM; Zemlan FP
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):28-33. PubMed ID: 2147899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Cognitive Dysfunction Caused by Anticholinergic Burden in Japanese Alzheimer's Disease Patients, Using the Most Commonly Used Scales in Japan.
    Konishi K; Hori K; Hachisu M; Tomioka H; Tani M; Hosoi M; Kitajima Y; Inamoto A; Iwanami A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2015 Nov; 35(5-6):113-8. PubMed ID: 26785521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease.
    Hachisu M; Konishi K; Hosoi M; Tani M; Tomioka H; Kitajima Y; Inamoto A; Hirata A; Koganemaru T; Tomita A; Akashi N; Hori K
    Neurodegener Dis; 2015; 15(3):134-9. PubMed ID: 26138490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral outcomes in clinical trials for Alzheimer disease.
    Ferris SH; Mackell JA
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.
    Fox C; Livingston G; Maidment ID; Coulton S; Smithard DG; Boustani M; Katona C
    Age Ageing; 2011 Nov; 40(6):730-5. PubMed ID: 21926432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small longitudinal study of serum anticholinergic activity and cognitive change in community-dwelling older adults.
    Kashyap M; Mulsant BH; Tannenbaum C
    Am J Geriatr Psychiatry; 2015 Mar; 23(3):326-9. PubMed ID: 25450763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone.
    Tracy JI; Monaco CA; Abraham G; Josiassen RC; Pollock BG
    J Clin Psychiatry; 1998 Apr; 59(4):184-8. PubMed ID: 9590669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.
    Mulsant BH; Pollock BG; Kirshner M; Shen C; Dodge H; Ganguli M
    Arch Gen Psychiatry; 2003 Feb; 60(2):198-203. PubMed ID: 12578438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease.
    Konishi K; Hori K; Tani M; Tomioka H; Kitajima Y; Akashi N; Inamoto A; Kurosawa K; Yuda H; Hanashi T; Ouchi H; Hosoi M; Hachisu M
    Neurodegener Dis; 2015; 15(3):149-56. PubMed ID: 26138492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Residence is not home' is a particular type of delusion associated with cognitive decline of Alzheimer's disease.
    Nakatsuka M; Meguro K; Nakamura K; Akanuma K; Yamaguchi S
    Dement Geriatr Cogn Disord; 2014; 38(1-2):46-54. PubMed ID: 24556941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
    Fujikawa T; Takahashi T; Kinoshita A; Kajiyama H; Kurata A; Yamashita H; Yamawaki S
    Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease.
    Tangwongchai S; Thavichachart N; Senanarong V; Poungvarin N; Phanthumchinda K; Praditsuwan R; Nidhinandana S; Chankrachang S
    Am J Alzheimers Dis Other Demen; 2008 Dec-2009 Jan; 23(6):593-601. PubMed ID: 18845693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
    Reisberg B; Borenstein J; Salob SP; Ferris SH; Franssen E; Georgotas A
    J Clin Psychiatry; 1987 May; 48 Suppl():9-15. PubMed ID: 3553166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.